Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032
SU2C-SARC032 研究表明,不同的肉瘤微环境可预测术前放疗和手术联合帕博利珠单抗治疗的获益。
期刊:
影响因子:
doi:10.1101/2025.11.01.25339299
Testa, Stefano; Himes, Jonathon E; Subramanian, Ajay; Nouth, Serey C L; Ballman, Karla V; Heise, Rachel S; Pierpoint, Matthew; Nemat-Gorgani, Neda; Sears, Timothy J; Binkley, Michael S; Kalbasi, Anusha; Corcoran, David L; Hong, Angela M; Brigman, Brian E; Riedel, Richard F; van de Rijn, Matt; Mowery, Yvonne M; Weinhold, Kent J; Kirsch, David G; Moding, Everett J